The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Perioperative immunochemotherapy (mDCF + avelumab) in locally advanced gastro-esophageal adenocarcinoma: A phase II trial.
 
Thierry Alcindor
Consulting or Advisory Role - Astellas Scientific and Medical Affairs Inc; AstraZeneca; Bayer; BMS; Merck
Research Funding - Astellas Pharma (Inst); Deciphera (Inst); EMD Serono (Inst); Epizyme (Inst); Karyopharm Therapeutics (Inst); SpringWorks Therapeutics (Inst)
 
Pierre-Olivier Fiset
No Relationships to Disclose
 
Touhid Opu
No Relationships to Disclose
 
Mehrnoush Dehghani
No Relationships to Disclose
 
Nicholas Bertos
No Relationships to Disclose
 
Carmen L. Mueller
No Relationships to Disclose
 
Jonathan Cools-Lartigue
No Relationships to Disclose
 
Marc Hickeson
No Relationships to Disclose
 
Victoria Marcus
No Relationships to Disclose
 
Sophie Camilleri-Broët
No Relationships to Disclose
 
Alan Spatz
Consulting or Advisory Role - Abbvie; AstraZeneca; Bayer; Bristol-Myers Squibb; Janssen; Merck; Novartis; Pfizer/EMD Serono; Roche
Research Funding - Bristol-Myers Squibb (Inst); Merck (Inst)
 
Gertruda Evaristo
No Relationships to Disclose
 
Mina Farag
No Relationships to Disclose
 
Giovanni Artho
No Relationships to Disclose
 
Arielle Elkrief
Other Relationship - Canadian Institutes of Health Research (CIHR); Cedars Cancer Center; Royal College of Surgeons and Physicians of Canada
 
Ramy Saleh
No Relationships to Disclose
 
Veena Sangwan
No Relationships to Disclose
 
Lorenzo Ferri
Honoraria - BMS GmbH & Co. KG; Boston Scientific; Merck/Pfizer